Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 405

1.

Repeated follow-up of AQP4-IgG titer by cell-based assay in neuromyelitis optica spectrum disorders (NMOSD).

Akaishi T, Takahashi T, Nakashima I, Abe M, Ishii T, Aoki M, Fujihara K.

J Neurol Sci. 2020 Jan 7;410:116671. doi: 10.1016/j.jns.2020.116671. [Epub ahead of print]

PMID:
31927341
2.

MOG-antibody-associated disease is different from MS and NMOSD and should be classified as a distinct disease entity - Commentary.

Fujihara K.

Mult Scler. 2019 Dec 17:1352458519895236. doi: 10.1177/1352458519895236. [Epub ahead of print] No abstract available.

PMID:
31842707
3.

Trial of Satralizumab in Neuromyelitis Optica Spectrum Disorder.

Yamamura T, Kleiter I, Fujihara K, Palace J, Greenberg B, Zakrzewska-Pniewska B, Patti F, Tsai CP, Saiz A, Yamazaki H, Kawata Y, Wright P, De Seze J.

N Engl J Med. 2019 Nov 28;381(22):2114-2124. doi: 10.1056/NEJMoa1901747.

PMID:
31774956
4.

Function of hTim8a in complex IV assembly in neuronal cells provides insight into pathomechanism underlying Mohr-Tranebjærg syndrome.

Kang Y, Anderson AJ, Jackson TD, Palmer CS, De Souza DP, Fujihara KM, Stait T, Frazier AE, Clemons NJ, Tull D, Thorburn DR, McConville MJ, Ryan MT, Stroud DA, Stojanovski D.

Elife. 2019 Nov 4;8. pii: e48828. doi: 10.7554/eLife.48828.

5.

Risk of coronary artery disease according to glucose abnormality status and prior coronary artery disease in Japanese men.

Kitazawa M, Fujihara K, Osawa T, Yamamoto M, Yamada MH, Kaneko M, Matsubayashi Y, Yamada T, Yamanaka N, Seida H, Sone H.

Metabolism. 2019 Dec;101:153991. doi: 10.1016/j.metabol.2019.153991. Epub 2019 Oct 27.

PMID:
31666194
6.

Patterns of regional brain volume loss in multiple sclerosis: a cluster analysis.

Fujimori J, Fujihara K, Ogawa R, Baba T, Wattjes M, Nakashima I.

J Neurol. 2019 Oct 25. doi: 10.1007/s00415-019-09595-4. [Epub ahead of print]

PMID:
31654116
7.

Glutamine + glutamate level predicts the magnitude of microstructural organization in the gray matter in the healthy elderly.

Motegi T, Narita K, Fujihara K, Kasagi M, Suzuki Y, Tagawa M, Ujita K, Near J, Fukuda M.

Int Psychogeriatr. 2019 Oct 3:1-9. doi: 10.1017/S1041610219001418. [Epub ahead of print]

PMID:
31578159
8.

Inebilizumab for the treatment of neuromyelitis optica spectrum disorder (N-MOmentum): a double-blind, randomised placebo-controlled phase 2/3 trial.

Cree BAC, Bennett JL, Kim HJ, Weinshenker BG, Pittock SJ, Wingerchuk DM, Fujihara K, Paul F, Cutter GR, Marignier R, Green AJ, Aktas O, Hartung HP, Lublin FD, Drappa J, Barron G, Madani S, Ratchford JN, She D, Cimbora D, Katz E; N-MOmentum study investigators.

Lancet. 2019 Oct 12;394(10206):1352-1363. doi: 10.1016/S0140-6736(19)31817-3. Epub 2019 Sep 5.

PMID:
31495497
9.

Long-term outcome of a group of Japanese children with myelin-oligodendrocyte glycoprotein encephalomyelitis without preventive immunosuppressive therapy.

Hino-Fukuyo N, Haginoya K, Takahashi T, Nakashima I, Fujihara K, Takai Y, Akasaka M, Kure S.

Brain Dev. 2019 Oct;41(9):790-795. doi: 10.1016/j.braindev.2019.06.004. Epub 2019 Jul 4.

PMID:
31281008
10.

Two Japanese cases of anti-MOG antibody-associated encephalitis that mimicked neuro-Behçet's disease.

Fujimori J, Takahashi T, Matsumoto Y, Fujihara K, Takai Y, Misu T, Nakashima I.

J Neuroimmunol. 2019 Sep 15;334:577002. doi: 10.1016/j.jneuroim.2019.577002. Epub 2019 Jun 29.

PMID:
31279093
11.

Loss of Glutamate Decarboxylase 67 in Somatostatin-Expressing Neurons Leads to Anxiety-Like Behavior and Alteration in the Akt/GSK3β Signaling Pathway.

Miyata S, Kumagaya R, Kakizaki T, Fujihara K, Wakamatsu K, Yanagawa Y.

Front Behav Neurosci. 2019 Jun 18;13:131. doi: 10.3389/fnbeh.2019.00131. eCollection 2019.

12.

Overt Proteinuria, Moderately Reduced eGFR and Their Combination Are Predictive of Severe Diabetic Retinopathy or Diabetic Macular Edema in Diabetes.

Yamamoto M, Fujihara K, Ishizawa M, Osawa T, Kaneko M, Ishiguro H, Matsubayashi Y, Seida H, Yamanaka N, Tanaka S, Kodama S, Hasebe H, Sone H.

Invest Ophthalmol Vis Sci. 2019 Jun 3;60(7):2685-2689. doi: 10.1167/iovs.19-26749.

PMID:
31242290
13.

[Current Status and Prospects of Complement-Targeting Therapy for Neuromyelitis Optica].

Kuroda H, Fujihara K.

Brain Nerve. 2019 Jun;71(6):573-580. doi: 10.11477/mf.1416201318. Review. Japanese.

PMID:
31171754
14.

Vitamin B6 intake and incidence of diabetic retinopathy in Japanese patients with type 2 diabetes: analysis of data from the Japan Diabetes Complications Study (JDCS).

Horikawa C, Aida R, Kamada C, Fujihara K, Tanaka S, Tanaka S, Araki A, Yoshimura Y, Moriya T, Akanuma Y, Sone H; Japan Diabetes Complications Study Group.

Eur J Nutr. 2019 May 31. doi: 10.1007/s00394-019-02014-4. [Epub ahead of print]

PMID:
31152214
15.

Eculizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder.

Pittock SJ, Berthele A, Fujihara K, Kim HJ, Levy M, Palace J, Nakashima I, Terzi M, Totolyan N, Viswanathan S, Wang KC, Pace A, Fujita KP, Armstrong R, Wingerchuk DM.

N Engl J Med. 2019 Aug 15;381(7):614-625. doi: 10.1056/NEJMoa1900866. Epub 2019 May 3.

PMID:
31050279
16.

Relationship Between Number of Multiple Risk Factors and Coronary Artery Disease Risk With and Without Diabetes Mellitus.

Yamada-Harada M, Fujihara K, Osawa T, Yamamoto M, Kaneko M, Kitazawa M, Matsubayashi Y, Yamada T, Yamanaka N, Seida H, Ogawa W, Sone H.

J Clin Endocrinol Metab. 2019 Nov 1;104(11):5084-5090. doi: 10.1210/jc.2019-00168.

PMID:
30994885
17.

Pulse Pressure is a Stronger Predictor Than Systolic Blood Pressure for Severe Eye Diseases in Diabetes Mellitus.

Yamamoto M, Fujihara K, Ishizawa M, Osawa T, Kaneko M, Ishiguro H, Matsubayashi Y, Seida H, Yamanaka N, Tanaka S, Kodama S, Hasebe H, Sone H.

J Am Heart Assoc. 2019 Apr 16;8(8):e010627. doi: 10.1161/JAHA.118.010627.

18.

Combined Effects of Energy Intake and Physical Activity on Obesity in Japanese Patients with Type 2 Diabetes (JDDM 50): A Cross-Sectional Study.

Hatta M, Fujihara K, Morikawa SY, Takeda Y, Ishii D, Horikawa C, Kato M, Yokoyama H, Kurihara Y, Iwasaki K, Miyazawa K, Yamazaki K, Tanaka S, Maegawa H, Sone H.

Diabetes Ther. 2019 Jun;10(3):1133-1138. doi: 10.1007/s13300-019-0610-x. Epub 2019 Apr 3.

19.

Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders.

Palace J, Lin DY, Zeng D, Majed M, Elsone L, Hamid S, Messina S, Misu T, Sagen J, Whittam D, Takai Y, Leite MI, Weinshenker B, Cabre P, Jacob A, Nakashima I, Fujihara K, Pittock SJ.

Brain. 2019 May 1;142(5):1310-1323. doi: 10.1093/brain/awz054.

20.

Neuromyelitis optica spectrum disorders: still evolving and broadening.

Fujihara K.

Curr Opin Neurol. 2019 Jun;32(3):385-394. doi: 10.1097/WCO.0000000000000694.

21.

Attenuation of Weight Loss Through Improved Antilipolytic Effect in Adipose Tissue Via the SGLT2 Inhibitor Tofogliflozin.

Yoshida A, Matsubayashi Y, Nojima T, Suganami H, Abe T, Ishizawa M, Fujihara K, Tanaka S, Kaku K, Sone H.

J Clin Endocrinol Metab. 2019 Sep 1;104(9):3647-3660. doi: 10.1210/jc.2018-02254.

PMID:
30811541
22.

Molecular comparison of interval and screen-detected breast cancers.

Cheasley D, Li N, Rowley SM, Elder K, Mann GB, Loi S, Savas P, Goode DL, Kader T, Zethoven M, Semple T, Fox SB, Pang JM, Byrne D, Devereux L, Nickson C, Procopio P, Lee G, Hughes S, Saunders H, Fujihara KM, Kuykhoven K, Connaughton J, James PA, Gorringe KL, Campbell IG.

J Pathol. 2019 Jun;248(2):243-252. doi: 10.1002/path.5251. Epub 2019 Mar 8.

PMID:
30746706
23.

Higher pulse pressure predicts initiation of dialysis in Japanese patients with diabetes.

Osawa T, Fujihara K, Harada M, Yamamoto M, Ishizawa M, Suzuki H, Ishiguro H, Matsubayashi Y, Seida H, Yamanaka N, Tanaka S, Shimano H, Kodama S, Sone H.

Diabetes Metab Res Rev. 2019 Mar;35(3):e3120. doi: 10.1002/dmrr.3120. Epub 2019 Jan 16.

PMID:
30578707
24.

Circulating AQP4-specific auto-antibodies alone can induce neuromyelitis optica spectrum disorder in the rat.

Hillebrand S, Schanda K, Nigritinou M, Tsymala I, Böhm D, Peschl P, Takai Y, Fujihara K, Nakashima I, Misu T, Reindl M, Lassmann H, Bradl M.

Acta Neuropathol. 2019 Mar;137(3):467-485. doi: 10.1007/s00401-018-1950-8. Epub 2018 Dec 18.

25.

Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations.

Juryńczyk M, Jacob A, Fujihara K, Palace J.

Pract Neurol. 2019 Jun;19(3):187-195. doi: 10.1136/practneurol-2017-001787. Epub 2018 Dec 8. Review.

PMID:
30530724
26.

Effect of family-oriented diabetes programs on glycemic control: A meta-analysis.

Kodama S, Morikawa S, Horikawa C, Ishii D, Fujihara K, Yamamoto M, Osawa T, Kitazawa M, Yamada T, Kato K, Tanaka S, Sone H.

Fam Pract. 2019 Jul 31;36(4):387-394. doi: 10.1093/fampra/cmy112.

PMID:
30423118
27.

TGF-beta signaling and its targeted therapy in gastrointestinal cancers.

Gotovac JR, Fujihara KM, Phillips WA, Clemons NJ.

Discov Med. 2018 Sep;26(142):103-112. Review.

28.

Network meta-analysis of the relative efficacy of bariatric surgeries for diabetes remission.

Kodama S, Fujihara K, Horikawa C, Harada M, Ishiguro H, Kaneko M, Furukawa K, Matsubayashi Y, Matsunaga S, Shimano H, Tanaka S, Kato K, Sone H.

Obes Rev. 2018 Dec;19(12):1621-1629. doi: 10.1111/obr.12751. Epub 2018 Sep 30. Review.

PMID:
30270528
29.

[MOG encephalomyelitis: international recommendations on diagnosis and antibody testing].

Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kümpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B.

Nervenarzt. 2018 Dec;89(12):1388-1399. doi: 10.1007/s00115-018-0607-0. Review. German.

PMID:
30264269
30.

Area postrema syndrome: Frequency, criteria, and severity in AQP4-IgG-positive NMOSD.

Shosha E, Dubey D, Palace J, Nakashima I, Jacob A, Fujihara K, Takahashi T, Whittam D, Leite MI, Misu T, Yoshiki T, Messina S, Elsone L, Majed M, Flanagan E, Gadoth A, Huebert C, Sagen J, Greenberg BM, Levy M, Banerjee A, Weinshenker B, Pittock SJ.

Neurology. 2018 Oct 23;91(17):e1642-e1651. doi: 10.1212/WNL.0000000000006392. Epub 2018 Sep 26.

31.

Association of treatment-achieved HbA1c with incidence of coronary artery disease and severe eye disease in diabetes patients.

Harada M, Fujihara K, Osawa T, Yamamoto M, Kaneko M, Ishizawa M, Matsubayashi Y, Yamada T, Yamanaka N, Seida H, Kodama S, Ogawa W, Sone H.

Diabetes Metab. 2018 Sep 10. pii: S1262-3636(18)30167-8. doi: 10.1016/j.diabet.2018.08.009. [Epub ahead of print]

PMID:
30213710
32.

Relationship between intake of fruit separately from vegetables and triglycerides - A meta-analysis.

Kodama S, Horikawa C, Fujihara K, Ishii D, Hatta M, Takeda Y, Kitazawa M, Matsubayashi Y, Shimano H, Kato K, Tanaka S, Sone H.

Clin Nutr ESPEN. 2018 Oct;27:53-58. doi: 10.1016/j.clnesp.2018.07.001. Epub 2018 Jul 13.

PMID:
30144893
33.

Physical Fitness Tests and Type 2 Diabetes Among Japanese: A Longitudinal Study From the Niigata Wellness Study.

Momma H, Sawada SS, Kato K, Gando Y, Kawakami R, Miyachi M, Huang C, Nagatomi R, Tashiro M, Ishizawa M, Kodama S, Iwanaga M, Fujihara K, Sone H.

J Epidemiol. 2019 Apr 5;29(4):139-146. doi: 10.2188/jea.JE20170280. Epub 2018 Jul 28.

34.

[FreeSurfer as a Platform for Associating Brain Structure with Function].

Fujihara K, Takei Y.

Brain Nerve. 2018 Jul;70(7):841-848. doi: 10.11477/mf.1416201085. Review. Japanese.

PMID:
29997280
35.

CSF cytokine profile in MOG-IgG+ neurological disease is similar to AQP4-IgG+ NMOSD but distinct from MS: a cross-sectional study and potential therapeutic implications.

Kaneko K, Sato DK, Nakashima I, Ogawa R, Akaishi T, Takai Y, Nishiyama S, Takahashi T, Misu T, Kuroda H, Tanaka S, Nomura K, Hashimoto Y, Callegaro D, Steinman L, Fujihara K, Aoki M.

J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):927-936. doi: 10.1136/jnnp-2018-317969. Epub 2018 Jun 6. Erratum in: J Neurol Neurosurg Psychiatry. 2019 Apr;90(4):e4.

36.

Transient Pulmonary Interstitial Lesions in Aquaporin-4-positive Neuromyelitis Optica Spectrum Disorder.

Asato Y, Kamitani T, Ootsuka K, Kuramochi M, Nakanishi K, Shimada T, Takahashi T, Misu T, Aoki M, Fujihara K, Kawabata Y.

Intern Med. 2018 Oct 15;57(20):2981-2986. doi: 10.2169/internalmedicine.0580-17. Epub 2018 May 18.

37.

Malondialdehyde-modified LDL-related variables are associated with diabetic kidney disease in type 2 diabetes.

Furukawa S, Suzuki H, Fujihara K, Kobayashi K, Iwasaki H, Sugano Y, Yatoh S, Sekiya M, Yahagi N, Shimano H.

Diabetes Res Clin Pract. 2018 Jul;141:237-243. doi: 10.1016/j.diabres.2018.05.019. Epub 2018 May 26.

PMID:
29775676
38.

Fingolimod-associated PML with mild IRIS in MS: A clinicopathologic study.

Nishiyama S, Misu T, Shishido-Hara Y, Nakamichi K, Saijo M, Takai Y, Takei K, Yamamoto N, Kuroda H, Saito R, Watanabe M, Tominaga T, Nakashima I, Fujihara K, Aoki M.

Neurol Neuroimmunol Neuroinflamm. 2017 Nov 10;5(1):e415. doi: 10.1212/NXI.0000000000000415. eCollection 2018 Jan.

39.

MOG encephalomyelitis: international recommendations on diagnosis and antibody testing.

Jarius S, Paul F, Aktas O, Asgari N, Dale RC, de Seze J, Franciotta D, Fujihara K, Jacob A, Kim HJ, Kleiter I, Kümpfel T, Levy M, Palace J, Ruprecht K, Saiz A, Trebst C, Weinshenker BG, Wildemann B.

J Neuroinflammation. 2018 May 3;15(1):134. doi: 10.1186/s12974-018-1144-2. Review.

40.

Cardiovascular Disease in Japanese Patients with Type 2 Diabetes Mellitus.

Fujihara K, Sone H.

Ann Vasc Dis. 2018 Mar 25;11(1):2-14. doi: 10.3400/avd.ra.17-00109. Review.

41.

MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.

Dos Passos GR, Oliveira LM, da Costa BK, Apostolos-Pereira SL, Callegaro D, Fujihara K, Sato DK.

Front Neurol. 2018 Apr 4;9:217. doi: 10.3389/fneur.2018.00217. eCollection 2018. Review.

42.

γ-Aminobutyric acid type A receptor binding affinity in the right inferior frontal gyrus at resting state predicts the performance of healthy elderly people in the visual sustained attention test.

Kasagi M, Motegi T, Narita K, Fujihara K, Suzuki Y, Tagawa M, Ujita K, Shimada H, Fukuda M.

Int Psychogeriatr. 2018 Sep;30(9):1385-1391. doi: 10.1017/S1041610217002988. Epub 2018 Mar 21.

PMID:
29559018
43.

Severe aquaporin 4-IgG-positive neuromyelitis optica with disseminated herpes zoster in a pregnant woman successfully treated with intravenous immunoglobulin.

Matsumoto Y, Tsuchiya M, Norshalena S, Kaneko C, Kubo J, Yamamoto T, Takahashi T, Fujihara K.

Mult Scler J Exp Transl Clin. 2018 Mar 9;4(1):2055217318758119. doi: 10.1177/2055217318758119. eCollection 2018 Jan-Mar.

44.

Association between Scale-Free Brain Dynamics and Behavioral Performance: Functional MRI Study in Resting State and Face Processing Task.

Kasagi M, Huang Z, Narita K, Shitara H, Motegi T, Suzuki Y, Fujihara K, Tanabe S, Kosaka H, Ujita K, Fukuda M, Northoff G.

Behav Neurol. 2017;2017:2824615. doi: 10.1155/2017/2824615. Epub 2017 Dec 21.

45.

Children with myelin oligodendrocyte glycoprotein antibodies-associated disease: relation of phenotypes to central nervous system myelin maturation.

Kuroda H, Fujihara K.

Dev Med Child Neurol. 2018 Apr;60(4):339-340. doi: 10.1111/dmcn.13691. Epub 2018 Feb 6. No abstract available.

46.

Role of fatty liver in the association between obesity and reduced hepatic insulin clearance.

Matsubayashi Y, Yoshida A, Suganami H, Ishiguro H, Yamamoto M, Fujihara K, Kodama S, Tanaka S, Kaku K, Sone H.

Diabetes Metab. 2018 Mar;44(2):135-142. doi: 10.1016/j.diabet.2017.12.003. Epub 2017 Dec 11.

PMID:
29395810
47.

Bridging the molecular divide: alcohol-induced downregulation of PAX9 and tumour development.

Fujihara KM, Clemons NJ.

J Pathol. 2018 Apr;244(4):386-388. doi: 10.1002/path.5041. Epub 2018 Feb 26.

PMID:
29344962
48.

Nationwide epidemiological study of neuromyelitis optica in Japan.

Miyamoto K, Fujihara K, Kira JI, Kuriyama N, Matsui M, Tamakoshi A, Kusunoki S.

J Neurol Neurosurg Psychiatry. 2018 Jun;89(6):667-668. doi: 10.1136/jnnp-2017-317321. Epub 2018 Jan 11. No abstract available.

PMID:
29326292
49.

Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.

Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Correale J, Fazekas F, Filippi M, Freedman MS, Fujihara K, Galetta SL, Hartung HP, Kappos L, Lublin FD, Marrie RA, Miller AE, Miller DH, Montalban X, Mowry EM, Sorensen PS, Tintoré M, Traboulsee AL, Trojano M, Uitdehaag BMJ, Vukusic S, Waubant E, Weinshenker BG, Reingold SC, Cohen JA.

Lancet Neurol. 2018 Feb;17(2):162-173. doi: 10.1016/S1474-4422(17)30470-2. Epub 2017 Dec 21. Review.

PMID:
29275977
50.

Relationships among cardiorespiratory fitness, muscular fitness, and cardiometabolic risk factors in Japanese adolescents: Niigata screening for and preventing the development of non-communicable disease study-Agano (NICE EVIDENCE Study-Agano) 2.

Morikawa SY, Fujihara K, Hatta M, Osawa T, Ishizawa M, Yamamoto M, Furukawa K, Ishiguro H, Matsunaga S, Ogawa Y, Shimano H, Sone H.

Pediatr Diabetes. 2018 Jun;19(4):593-602. doi: 10.1111/pedi.12623. Epub 2017 Dec 19.

PMID:
29266622

Supplemental Content

Loading ...
Support Center